Ignite Creation Date:
2025-12-25 @ 2:40 AM
Ignite Modification Date:
2026-03-02 @ 11:14 PM
Study NCT ID:
NCT00165633
Status:
TERMINATED
Last Update Posted:
2008-12-09
First Post:
2005-09-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma
Sponsor:
Eisai Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
E0167-J081-551
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Customer Information Services Department. CRC and QA
Old Organization:
Eisai Company Limited